Prolonged dual antiplatelet therapy in selected patients with acute coronary syndrome. Issue 1 (7th January 2022)

• Record Type: Journal Article
• Authors: Spirito, Alessandro; Mehran, Roxana
• Is Part Of: Catheterization and cardiovascular interventions. Volume 99:Issue 1(2022)
• Page Start: 114
• Page End: 115
• Publication Date: 2022-01-07
• Subjects: Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.30032
• Languages: English
• ISSNs: 1522-1946

Abstract

Key Points: It is crucial to identify patients with an increased bleeding or ischemic risk that may benefit from a tailored antiplatelet regimen. This study confirmed the benefit of a prolonged DAPT (≥12 months) in reducing ischemic events without bleeding harm in a real world East Asian population presenting with acute coronary syndrome and additional clinical and angiographic high‐risk features. An alternative approach, consisting of a prolonged P2Y12 monotherapy, is under investigation in this patient subset.